Galectin Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $24k | 15k | 1.66 |
| 2023-06-30 | $18k | 13k | 1.44 |
| 2023-03-31 | $47k | 22k | 2.10 |
| 2022-12-31 | $100k | 88k | 1.13 |
| 2022-06-30 | $14k | 11k | 1.31 |
| 2022-03-31 | $37k | 23k | 1.62 |
| 2021-12-31 | $252k | 121k | 2.08 |
| 2021-09-30 | $492k | 127k | 3.87 |
| 2021-06-30 | $248k | 78k | 3.19 |
| 2021-03-31 | $53k | 25k | 2.16 |
| 2020-12-31 | $182k | 81k | 2.24 |
| 2020-09-30 | $110k | 41k | 2.67 |
| 2020-06-30 | $168k | 50k | 3.34 |
| 2020-03-31 | $181k | 93k | 1.96 |
| 2019-12-31 | $227k | 79k | 2.89 |
| 2019-09-30 | $399k | 108k | 3.68 |
| 2019-06-30 | $273k | 66k | 4.16 |
| 2019-03-31 | $508k | 100k | 5.10 |
| 2018-12-31 | $464k | 135k | 3.43 |
| 2018-09-30 | $695k | 116k | 6.01 |
| 2018-06-30 | $669k | 105k | 6.37 |
| 2018-03-31 | $480k | 101k | 4.74 |
| 2017-12-31 | $173k | 52k | 3.33 |
| 2017-09-30 | $45k | 21k | 2.12 |
| 2017-06-30 | $166k | 67k | 2.48 |
| 2017-03-31 | $208k | 90k | 2.30 |
| 2016-12-31 | $38k | 39k | 0.98 |
| 2016-09-30 | $58k | 52k | 1.13 |
| 2016-06-30 | $20k | 14k | 1.45 |
| 2015-09-30 | $21k | 8.8k | 2.38 |
| 2014-12-31 | $24k | 6.9k | 3.48 |
| 2014-09-30 | $101k | 20k | 5.05 |
| 2014-06-30 | $37k | 2.7k | 13.71 |